Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia

Published:2015-10-22 Issue:1 Volume:97 Page:33-38
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Xicoy Blanca¹,Germing Ulrich²,Jimenez María-José¹,Garcia Olga¹,Garcia Regina¹,Schemenau Jeniffer²,Pedro Carme¹,Luño Elisa¹,Bernal Teresa¹,González Bernardo¹,Strupp Corinna²,Ardanaz Maite¹,Kuendgen Andrea²,Cedena María-Teresa¹,Neukirchen Judith²,Calabuig Marisa¹,Brunet Salut¹,Medina Angeles¹,Amigo María-Luz¹,Ramos Fernando¹,Callejas Marta¹,Díez-Campelo María¹,Bailén Alicia¹,Collado Rosa¹,Vicente Ana¹,Arnan Montserrat¹,Valcarcel David¹,Arilla María Jesús¹,Zamora Lurdes¹,Benlloch Luis¹,Sanz Guillermo¹

Affiliation:

1. Spanish Registry of MDS; Valencia Spain

2. Department of Hematology; Oncology and Clinical Immunology; Heinrich-Heine Universitätsklinikum Düsseldorf; Düsseldorf Germany

Funder

Josep Carreras Leukemia Research Institute

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12679/fullpdf

Reference26 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. Cytogenetic risk stratification in chronic myelomonocytic leukemia;Such;Haematologica,2011

3. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia;Such;Blood,2013

4. Myelodysplastic/myeloproliferative neoplasms;Cazzola;Hematology Am Soc Hematol Educ Program,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDS patient registries - achievements and challenges;Annals of Hematology;2024-08-23

2. Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis;Frontiers in Oncology;2024-07-01

3. Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia;Current Treatment Options in Oncology;2023-06-10

4. Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia;Current Opinion in Hematology;2021-10-19

5. Chronic Myelomonocytic Leukemia Gold Jubilee;Hemato;2021-07-01